FORA Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-59,696
Closed -$4.77M 465
2025
Q3
$4.77M Buy
59,696
+36,844
+161% +$3.14M 0.84% 20
2025
Q2
$2.08M Buy
+22,852
New +$2.09M 0.23% 114
2025
Q1
Sell
-30,544
Closed -$2.78M 519
2024
Q4
$2.78M Buy
+30,544
New +$2.91M 0.32% 105
2023
Q4
Sell
-18,099
Closed -$1.29M 459
2023
Q3
$1.29M Buy
+18,099
New +$1.35M 0.11% 211
2023
Q2
Sell
-46,021
Closed -$3.46M 387
2023
Q1
$3.46M Buy
+46,021
New +$3.42M 0.35% 85
2022
Q2
Sell
-53,858
Closed -$4.11M 458
2022
Q1
$4.11M Buy
53,858
+49,897
+1,260% +$3.95M 0.74% 23
2021
Q4
$338K Sell
3,961
-8,552
-68% -$668K 0.13% 207
2021
Q3
$946K Buy
+12,513
New +$994K 0.24% 126
2021
Q1
Sell
-12,118
Closed -$1.04M 815
2020
Q4
$1.04M Buy
12,118
+8,119
+203% +$671K 0.16% 142
2020
Q3
$309K Sell
3,999
-1,910
-32% -$146K 0.2% 114
2020
Q2
$433K Sell
5,909
-23,463
-80% -$1.67M 0.15% 181
2020
Q1
$1.95M Sell
29,372
-32,194
-52% -$2.27M 0.42% 46
2019
Q4
$4.24M Buy
+61,566
New +$4.2M 0.43% 38

Other funds holding CL

FORA Capital's CL Position: Q4 2025 in Review

FORA Capital sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 59,696 shares — an estimated $4.77M sold.

FORA Capital first reported a position in CL in Q4 2019 and held it in 13 quarters. The position peaked at $4.77M in Q3 2025. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • FORA Capital reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • FORA Capital sold 59,696 Colgate-Palmolive shares in Q4 2025, an estimated $4.77M.
  • FORA Capital first reported a position in Colgate-Palmolive in Q4 2019 and held it in 13 quarters.
  • FORA Capital's Colgate-Palmolive position peaked at $4.77M in Q3 2025.
  • 1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on FORA Capital's 13F filing for Q4 2025, filed 13 Feb 2026.